Abstract Posterior Segment Eye Diseases (PSED) are the major cause of visual impairment
globally that directly affects the patients' quality of life, especially in the aging population.
Vascular degenerative disorders of posterior eye are the vision threatening disorders,
involving inflammation as one of the main pathological mechanisms. Use of current
treatment regimens for PSED is significantly limited on account of unique environment of the
eye that offers a major barrier to the delivery of efficient drug doses to the posterior segment …